South America Asthma Inhaler Device Market
South America Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices), By End User (Hospitals & Clinics, Homecare) andBy Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035
Industry Developments
Recent developments in the South America Asthma Inhaler Device Market have indicated an increasing focus on innovation and accessibility. Among significant players, Pfizer, AbbVie, and GlaxoSmithKline are ramping up efforts in Research and Development to enhance device efficacy and patient adherence. Current trends show a rise in the demand for digital inhalers, as they provide better management capabilities through connected technology. Meanwhile, Boehringer Ingelheim and Roche are actively promoting their latest inhalation therapies, addressing the growing prevalence of asthma in the region. In terms of mergers and acquisitions, Novartis acquired certain assets from a local firm in August 2023, aiming to boost its foothold in South America. As for market valuation, firms like Teva Pharmaceuticals and AstraZeneca have reported notable growth, contributing to a combined market increase of 15% in device sales over the past two years, specifically from April 2022 to April 2023. Regulatory frameworks are also evolving, with health authorities in Brazil and Argentina implementing policies to improve patient access to inhaler devices, underlining the increasing prioritization of asthma management in health agendas across South America.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 112.0(USD Million) |
| MARKET SIZE 2024 | 123.2(USD Million) |
| MARKET SIZE 2035 | 309.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.719% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pfizer, AbbVie, GlaxoSmithKline, Roche, Boehringer Ingelheim, Orion Corporation, Chiesi Farmaceutici, Mylan, Novartis, Sanofi, Elekta, AstraZeneca, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Merck & Co |
| SEGMENTS COVERED | Type, Mode of Operation, End User, Regional |
| KEY MARKET OPPORTUNITIES | Rising asthma prevalence, Increasing healthcare access, Advanced device technology adoption, Growing awareness of inhaler types, Expansion of telemedicine solutions |
| KEY MARKET DYNAMICS | increasing asthma prevalence, rising healthcare expenditure, technological advancements in devices, growing awareness and education, government support and regulations |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
FAQs
What is the expected market size of the South America Asthma Inhaler Device Market in 2024?
The South America Asthma Inhaler Device Market is expected to be valued at 123.2 million USD in 2024.
What is the forecasted market size for the South America Asthma Inhaler Device Market by 2035?
By 2035, the South America Asthma Inhaler Device Market is projected to reach 309.0 million USD.
What is the expected compound annual growth rate (CAGR) for the South America Asthma Inhaler Device Market from 2025 to 2035?
The market is expected to grow at a CAGR of 8.719% from 2025 to 2035.
Which type of asthma inhaler is expected to dominate the South America market in 2024?
Metered Dose Inhalers are expected to dominate with a valuation of 65.0 million USD in 2024.
What is the projected market value of Dry Powder Inhalers in 2035?
The Dry Powder Inhalers market is projected to be valued at 92.5 million USD by 2035.
What market share does Brazil hold in the South America Asthma Inhaler Device Market in 2024?
Brazil's market share is expected to be valued at 45.0 million USD in 2024.
What is the expected market size of Soft Mist Inhalers in 2024?
Soft Mist Inhalers are expected to have a market size of 20.2 million USD in 2024.
What is the projected market size for Argentina in the Asthma Inhaler Device Market by 2035?
By 2035, Argentina's market size is expected to reach 50.0 million USD.
Who are the major players in the South America Asthma Inhaler Device Market?
Key players in the market include Pfizer, AbbVie, GlaxoSmithKline, Roche, and Boehringer Ingelheim.
What is the expected market value for the Rest of South America region in 2035?
The Rest of South America is projected to have a market value of 78.0 million USD by 2035.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”